• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Graves 眼病患者血清白细胞介素-17 水平升高。

Increased serum interleukin-17 in Graves' ophthalmopathy.

机构信息

Department of Ophthalmology, Myongji Hospital, Kwandong University College of Medicine, Koyang, 412-270, Korea.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2012 Oct;250(10):1521-6. doi: 10.1007/s00417-012-2092-7. Epub 2012 Jul 1.

DOI:10.1007/s00417-012-2092-7
PMID:22752189
Abstract

BACKGROUND

Interleukin (IL)-17 and T helper 17 (Th17) cells are reported to be involved in many autoimmune diseases. The aim of this study is to investigate the involvement of IL-17 in the pathogenesis and disease activity of Graves' ophthalmopathy (GO).

METHODS

Sixty-two GO patients and 19 healthy controls were recruited. Serum concentrations of cytokines, IL-17, IL-6, IL-23, and IL-16, were measured using multiplexed microsphere-based flow cytometric immunoassays. GO hormonal parameters, clinical activity score (CAS), exophthalmometry, and extraocular muscle involvement were evaluated, and relationships with cytokine concentrations were analyzed.

RESULTS

The concentration and positive detection rates of serum IL-17 were significantly higher in patients with GO than in controls. The serum levels of IL-17 in active GO patients were higher than that of inactive GO patients. Serum IL-17 concentration had significant correlation with CAS (p < 0.001).

CONCLUSION

The increased serum level of IL-17 and related cytokines in GO patients and the correlation of IL-17 concentration with the clinical activity scores suggest that IL-17 may play a pathophysiological role in GO.

摘要

背景

白细胞介素(IL)-17 和辅助性 T 细胞 17(Th17)细胞被报道参与许多自身免疫性疾病。本研究旨在探讨 IL-17 在格雷夫斯眼病(GO)发病机制和疾病活动中的作用。

方法

招募了 62 例 GO 患者和 19 名健康对照者。采用基于多重微球的流式细胞术免疫分析检测细胞因子、IL-17、IL-6、IL-23 和 IL-16 的血清浓度。评估 GO 激素参数、临床活动评分(CAS)、眼球突出度和眼外肌受累情况,并分析与细胞因子浓度的关系。

结果

GO 患者血清 IL-17 的浓度和阳性检出率明显高于对照组。活动期 GO 患者的血清 IL-17 水平高于非活动期 GO 患者。血清 IL-17 浓度与 CAS 显著相关(p<0.001)。

结论

GO 患者血清中 IL-17 及相关细胞因子水平升高,IL-17 浓度与临床活动评分相关,提示 IL-17 可能在 GO 中发挥病理生理作用。

相似文献

1
Increased serum interleukin-17 in Graves' ophthalmopathy.Graves 眼病患者血清白细胞介素-17 水平升高。
Graefes Arch Clin Exp Ophthalmol. 2012 Oct;250(10):1521-6. doi: 10.1007/s00417-012-2092-7. Epub 2012 Jul 1.
2
Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy.促甲状腺素受体抗体、甲状腺刺激抗体及甲状腺阻断抗体与格雷夫斯眼病临床活动评分及严重程度的关联
Acta Med Indones. 2012 Apr;44(2):114-21.
3
Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.Th1、Th2和Th17细胞因子与甲状腺相关性眼病的关系
Dis Markers. 2015;2015:609593. doi: 10.1155/2015/609593. Epub 2015 May 18.
4
Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy.微小RNA-146a(miR-146a)和白细胞介素-17(IL-17)的循环水平与格雷夫斯眼病的临床活动度显著相关。
Endocr J. 2014;61(11):1087-92. doi: 10.1507/endocrj.ej14-0246. Epub 2014 Aug 7.
5
Interaction of MMP-9 in the active phase of Graves' disease with and without ophthalmopathy.格雷夫斯病活动期伴或不伴眼病患者 MMP-9 的相互作用。
Am J Physiol Endocrinol Metab. 2024 Oct 1;327(4):E577-E584. doi: 10.1152/ajpendo.00166.2024. Epub 2024 Sep 11.
6
CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.CD4 + T细胞和Th1/Th2失衡与格雷夫斯眼病的发病机制有关。
Int J Mol Med. 2006 May;17(5):911-6.
7
Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy.烟酰胺磷酸核糖基转移酶在Graves眼病患者白细胞中的过表达
Endocrine. 2016 Aug;53(2):497-504. doi: 10.1007/s12020-015-0855-8. Epub 2016 Jan 14.
8
Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.促甲状腺素抗体与格雷夫斯眼病有关,但促甲状腺素结合抑制免疫球蛋白与格雷夫斯病患者的甲状腺功能亢进有关。
Thyroid. 2000 Sep;10(9):809-13. doi: 10.1089/thy.2000.10.809.
9
TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.采用第三代检测方法测定的促甲状腺激素受体抗体滴度,不能反映未经治疗的日本格雷夫斯病患者格雷夫斯眼病的活动情况。
Endocr J. 2016;63(2):151-7. doi: 10.1507/endocrj.EJ15-0137. Epub 2015 Nov 18.
10
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule.非毒性甲状腺结节经皮乙醇注射后发生严重 Graves 眼病。
Thyroid. 2012 Feb;22(2):210-3. doi: 10.1089/thy.2011.0315. Epub 2011 Dec 23.

引用本文的文献

1
Redefining Treatment Paradigms in Thyroid Eye Disease: Current and Future Therapeutic Strategies.重新定义甲状腺眼病的治疗模式:当前及未来的治疗策略
J Clin Med. 2025 Aug 6;14(15):5528. doi: 10.3390/jcm14155528.
2
Hashimoto's Thyroiditis and Dry Eye Disease.桥本甲状腺炎与干眼症
J Clin Med. 2025 Mar 4;14(5):1710. doi: 10.3390/jcm14051710.
3
Novel perspectives on the pharmacological treatment of thyroid-associated ophthalmopathy.甲状腺相关性眼病药物治疗的新观点

本文引用的文献

1
Neuro-endocrine correlations of hypothalamic-pituitary-thyroid axis in healthy humans.健康人体下丘脑-垂体-甲状腺轴的神经内分泌相关性。
J Biol Regul Homeost Agents. 2011 Apr-Jun;25(2):249-57.
2
Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease.帕金森病患者生长激素、促甲状腺激素和催乳素的日分泌谱。
J Neuroendocrinol. 2011 Jun;23(6):519-24. doi: 10.1111/j.1365-2826.2011.02134.x.
3
Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds.
Front Endocrinol (Lausanne). 2025 Jan 13;15:1469268. doi: 10.3389/fendo.2024.1469268. eCollection 2024.
4
Interaction of MMP-9 in the active phase of Graves' disease with and without ophthalmopathy.格雷夫斯病活动期伴或不伴眼病患者 MMP-9 的相互作用。
Am J Physiol Endocrinol Metab. 2024 Oct 1;327(4):E577-E584. doi: 10.1152/ajpendo.00166.2024. Epub 2024 Sep 11.
5
Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets.眼眶中的免疫过程以及当前和潜在药物靶点的适应症
J Clin Med. 2023 Dec 22;13(1):72. doi: 10.3390/jcm13010072.
6
Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy.基于格雷夫斯眼病发病机制的现有及有前景的治疗方法。
Front Pharmacol. 2023 Nov 16;14:1217253. doi: 10.3389/fphar.2023.1217253. eCollection 2023.
7
Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves' Ophthalmopathy.Graves 眼病患者结膜杯状细胞和泪液 MUC5AC 蛋白的研究。
Transl Vis Sci Technol. 2023 Oct 3;12(10):19. doi: 10.1167/tvst.12.10.19.
8
Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review.非编码RNA介导的格雷夫斯眼病表观遗传改变:一项范围界定性系统评价
Noncoding RNA Res. 2023 May 16;8(3):426-450. doi: 10.1016/j.ncrna.2023.04.001. eCollection 2023 Sep.
9
Elevated expression of interleukin-27, IL-35, and decreased IL-12 in patients with thyroid-associated ophthalmopathy.甲状腺相关性眼病患者中白细胞介素-27、IL-35表达升高,而白细胞介素-12表达降低。
Graefes Arch Clin Exp Ophthalmol. 2023 Apr;261(4):1091-1100. doi: 10.1007/s00417-022-05856-7. Epub 2022 Nov 12.
10
Comprehensive analysis of key genes and pathways for biological and clinical implications in thyroid-associated ophthalmopathy.甲状腺相关眼病的生物学和临床意义的关键基因和通路的综合分析。
BMC Genomics. 2022 Sep 2;23(1):630. doi: 10.1186/s12864-022-08854-5.
辅助性 T 细胞 17 型免疫应答在不同遗传背景的 Graves 甲亢小鼠中的独特作用。
Autoimmunity. 2011 Mar;44(2):159-65. doi: 10.3109/08916931003777247. Epub 2010 Jul 29.
4
Graves' ophthalmopathy.格雷夫斯眼病。
N Engl J Med. 2010 Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750.
5
Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis.桥本甲状腺炎患者循环中促炎细胞因子和 Th17 淋巴细胞增加。
J Clin Endocrinol Metab. 2010 Feb;95(2):953-62. doi: 10.1210/jc.2009-1719. Epub 2009 Dec 16.
6
Interleukin-17 and systemic lupus erythematosus: current concepts.白细胞介素-17与系统性红斑狼疮:当前概念
Clin Exp Immunol. 2009 Aug;157(2):209-15. doi: 10.1111/j.1365-2249.2009.03944.x.
7
Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.重度桥本氏病中Th1/Th2细胞比例升高以及难治性格雷夫斯病中Th17细胞比例升高。
Thyroid. 2009 May;19(5):495-501. doi: 10.1089/thy.2008.0423.
8
Th17 cells in immunity and autoimmunity.免疫与自身免疫中的辅助性T细胞17
Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii26-9. doi: 10.1136/ard.2008.098004.
9
Induction, function and regulation of IL-17-producing T cells.产生白细胞介素-17的T细胞的诱导、功能及调控
Eur J Immunol. 2008 Oct;38(10):2636-49. doi: 10.1002/eji.200838535.
10
Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.干扰素-γ诱导白细胞介素-17阳性T细胞的迁移与发育:银屑病中的机制及病理相关性
J Immunol. 2008 Oct 1;181(7):4733-41. doi: 10.4049/jimmunol.181.7.4733.